Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • June 22, 2016:

    Scientists from The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas MD Anderson Cancer Center reported finding an obesity-induced switch, chemokine CXCL1, a signaling molecule that regulates cell trafficking. When the investigators blocked the switch in mouse models, the obesity-induced progression of prostate cancer slowed..Full Story

  • June 22, 2016:

    Sanofi, Langland and Mendor devloped a treatment method that is a patient-centric online clinical trial platform integrated with Mendor’s 3G-enabled wireless blood glucose meter in a completely remote clinical trial setting. Sixty patients — all recruited through Facebook — participated in the study with final results of a remote online Phase IV clinical trial for diabetes being successful.Full Story

  • June 18, 2016:

    A new study by a Yale researcher may support the use of a device called the Watchman which is a catheter-delivered device that is permanently implanted in the opening of the left atrial appendage (LAA), a small appendage of tissue that projects off one of the upper chambers of the heart. It prevents blood clots from forming in the left atrial appendage thus preventing strokes caused by the blood clots forming in the LAA.Full Story

  • June 13, 2016:

    ZOLL Medical Corp., manufacturer of medical devices and related software, reported that patients experience a high one-year survival rate following use of the LifeVest Wearable Defibrillator. The WEARIT-II prospective registry includes more than 2,000 patients prescribed the LifeVest Wearable Defibrillator with U.S. enrollment completed in 2015. One-year survival following use of the LifeVest across all patients was high at 97 percent.Full Story

  • June 1, 2016:

    During a five year study, Dr. Eri Srivatsan’s, UCLA Jonsson Comprehensive Cancer Center, team found that a protein known as cystatin E/M can inhibit cellular inflammation, which is a major contributor to the growth of cervical cancer. The UCLA researchers discovered that cystatin E/M prevents a protein called NFkB, which regulates inflammation, from entering the nucleus of cervical cancer cells. As a result, decreased inflammation slows tumor cell growth..Full Story

  • May 31, 2016:

    Northwestern Memorial Hospital is the first hospital to offer and perform the first procedure for the world's smallest FDA-approved pacemaker for patients with bradycardia, a condition characterized by a slow or irregular heart rhythm, usually fewer than 60 beats per minute. At this rate, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, and shortness of breath or fainting spells.Full Story

  • May 27, 2016:

    Jennifer Sweet, MD, a neurosurgeon at University Hospitals Case Medical Center, recently opened a clinical research study to learn if deep brain stimulation (DBS) can bring them relief to bipolar disorder patients. It is hoped that DBS can help such non-responsive patients, or perhaps down the line even patients whose response to drugs become less effective over time.Full Story

  • May 26, 2016:

    A new Multiphoton Microscope and Endoscope could speed up disease diagnosis. The lightweight handheld microscope designed to examine external tissue or tissue exposed during surgery. One example of its use could be to help surgeons compare normal and cancerous cells (during an operation). A key advantage is that the device can acquire high quality 3D images of parts of the body while patients are moving (e.g. due to normal breathing), enabling it to be applied to almost any exposed area of a patient's body. The second instrument, a tiny endoscope incorporating specially designed optical fibers and ultraprecise control of the light coupled into it, has the potential to be inserted into the body to carry out internal cell-scale examination, for example during neurosurgery. Ultimately, this new approach may be able to provide high resolution images enabling surgeons to see inside individual cells at an adjustable depth beneath the surface of the tissue.Full Story

  • May 26, 2016:

    BIOTRONIK today announced the launch of CardioMessenger Smart in the United States. CardioMessenger Smart is a portable monitoring device, about the size of a modern smartphone, that keeps pacemaker, implantable cardioverter defibrillator (ICD), and insertable cardiac monitor (ICM) patients connected to their physician remotely, enabling more efficient care management -anywhere in the world.Full Story